USANA Health Sciences Inc (USNA)
Pretax margin
| Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2020 | ||
|---|---|---|---|---|---|---|
| Earnings before tax but after interest (EBT) | US$ in thousands | 76,321 | 102,453 | 108,621 | 170,642 | 177,948 |
| Revenue | US$ in thousands | 856,858 | 923,915 | 1,001,720 | 1,190,170 | 1,137,750 |
| Pretax margin | 8.91% | 11.09% | 10.84% | 14.34% | 15.64% |
December 31, 2024 calculation
Pretax margin = EBT ÷ Revenue
= $76,321K ÷ $856,858K
= 8.91%
USANA Health Sciences Inc's pretax margin has experienced fluctuations over the years based on the provided data. In 2020, the pretax margin stood at 15.64%, reflecting a strong profitability level. However, in the following years, there was a slight decline, with the pretax margin decreasing to 14.34% in 2021 and further dropping to 10.84% in 2022. This suggests a potential trend of decreasing profitability or increasing expenses relative to revenue during these periods.
There was a minor improvement in 2023, with the pretax margin increasing to 11.09%, but it remained below the levels seen in 2020. By the end of 2024, the pretax margin dropped to 8.91%, indicating a significant decline compared to previous years.
Overall, the trend in USANA Health Sciences Inc's pretax margin shows some volatility, with periods of both improvement and deterioration. It would be important for stakeholders to closely monitor future financial performance to assess the company's ability to maintain or improve profitability levels.